![]() |
市场调查报告书
商品编码
1818063
全球药用饲料添加剂市场:预测至2032年-按产品类型、动物种类、剂型、分销管道、最终用户和地区进行分析Medicated Feed Additives Market Forecasts to 2032 - Global Analysis By Product Type, Animal Type, Formulation, Distribution Channel, End User, and By Geography |
根据 Stratistics MRC 的数据,全球药物饲料添加剂市场预计在 2025 年达到 168 亿美元,到 2032 年将达到 256 亿美元,预测期内的复合年增长率为 6.2%。
药用饲料添加剂是添加到牲畜饲料中,用于维持牲畜和家禽健康、预防疾病或治疗特定疾病的化合物。药用饲料添加剂兼具营养和治疗功效,能够促进生长、提高饲料效率和动物整体健康。这些添加剂包括抗生素、抗寄生虫药、维生素和矿物质,旨在维持牲畜健康、预防感染疾病并提高生产力。
根据欧洲食品安全局(EFSA)估计,欧盟国家每年报告32万例经由食物传染疾病和通用感染疾病,这可能会对药用饲料添加剂市场的收益成长产生正面影响。
驱动程式
对动物健康和福利的日益关注
人们对动物健康和伦理治疗意识的不断增强,推动了对药物饲料添加剂的需求。这些添加剂在预防疾病爆发、增强免疫力和提高动物整体生产力方面发挥关键作用。消费者和监管机构日益严格的审查,促使生产者优先考虑注重动物福利的解决方案,以减少对抗生素的依赖。药物添加剂在提供针对性治疗益处的同时,也支持永续的农业实践。对更高品质肉类和乳製品的需求也推动了它们在商业农场的应用。随着全球动物福利标准的收紧,这些添加剂正成为负责任畜牧业的必备工具。
供应链中断和价格波动
药用饲料添加剂面临供应链不稳定和原料成本波动的挑战。活性成分、维生素和矿物质采购中断可能会导致生产延误并造成库存紧张。药物化合物和饲料化学品的价格波动会影响盈利和采购计画。这种不确定性对于缓衝能力有限的小型製造商来说尤其成问题。监管延迟和进口限制进一步加剧了物流复杂化,尤其是在新兴市场。总体而言,供应链脆弱性和不可预测的成本仍然是市场持续成长的主要障碍。
精准牲畜营养的兴起
精准牲畜营养的转变正在为药物饲料添加剂开闢新的成长途径。酪农和畜牧生产者越来越多地采用数据主导的方法,根据品种、年龄和健康状况优化饲料配方。这一趋势推动了针对性添加剂的使用,这些添加剂能够在不过量的情况下提供治疗效果。饲料技术和诊断技术的创新使得剂量更精准,健康状况更佳。随着永续性和效率成为畜牧生产的核心,精准营养在家禽、猪和反刍动物领域日益普及。药物添加剂有望从饲料策略的这一演变中获益。
与替代品的竞争
益生菌、植物性成分和有机饲料补充剂等替代性健康解决方案正给市场带来压力。由于消费者对天然、无抗生素畜产品的需求不断增长,这些替代品越来越受欢迎。有利于非药物介入的监管变化也影响购买决策。在某些情况下,生产商正在转向整体健康管理策略,以减少对合成添加剂的依赖。洁净标示动物产品日益增长的吸引力对传统的药物饲料解决方案构成了直接挑战。因此,来自替代品的竞争正在改变市场格局并迫使企业进行创新。
COVID-19的影响
疫情最初导致供应链中断和农场活动减少,扰乱了药物饲料添加剂市场。停工影响了饲料生产、兽医服务和分销网络,造成了暂时的挫折。然而,家禽和酪农等关键产业的需求有助于缓解疫情的影响。这场危机也凸显了疾病预防和生物安全的重要性,提升了药物添加物的价值。随着復工復产,生产商优先考虑具有韧性、以健康为中心的饲养策略,以降低未来的风险。
抗生素市场预计将成为预测期内最大的市场
预计抗生素领域将在预测期内占据最大的市场份额,这主要得益于对动物健康、生长率和饲料转换效率提升的需求。控制释放和微胶囊技术等技术创新正在提高给药精度和药物稳定性。精准饲餵和益生菌的整合应用正逐渐成为降低抗生素依赖的趋势。监管变化,尤其是在欧洲和亚洲,也推动了配方改革和永续替代品的研发,因为製造商正在适应更严格的兽医合规性和不断发展的畜牧管理标准。
预测期内饲料製造商预计将以最高复合年增长率成长
饲料製造业专注于动物健康、生产性能和监管合规,预计在预测期内将达到最高成长率。奈米配方和精准输送系统的突破性进展正在提高添加剂效率并最大限度地减少资源损失。植物源性成分和酵素基解决方案的显着转变正在取代传统抗生素。近期趋势,包括合作研发计划、数位可追溯性工具的采用以及与日益严格的法规相适应的再製造工作(尤其是在欧洲和亚太地区),正在推动饲料生产策略的创新和合规性。
由于动物性蛋白质消费量增加、畜牧管理实践改进以及疾病预防意识不断增强,预计亚太地区将在预测期内占据最大市场份额。奈米递送和精准剂量技术的创新正在提升添加剂的性能。天然酵素解决方案取代传统抗生素的趋势明显。嘉吉和硕腾等领先公司正在加强研发力度,而印度和中国日益严格的法规正在推动饲料配方改革和数位追溯系统的实施,以确保合规并优化饲料性能。
预计北美将在预测期内实现最高的复合年增长率,这得益于消费者对无抗生素肉类的需求不断增长、美国食品药品监督管理局(FDA)监管力度的加强以及人们对动物健康的日益关注。免疫支持和肠道靶向技术的进步正在提高添加剂的有效性。市场正转向天然和有机饲料,这反映了人们对永续性的偏好。硕腾和ADM等主要企业正在扩大其研发活动,数位可追溯平台也越来越受欢迎,有助于提高整个饲料供应链的合规性和透明度。
According to Stratistics MRC, the Global Medicated Feed Additives Market is accounted for $16.80 billion in 2025 and is expected to reach $25.60 billion by 2032 growing at a CAGR of 6.2% during the forecast period. Medicated Feed Additives are compounds added to animal feed to support health, prevent illnesses, or treat certain conditions in livestock and poultry. They provide both nutritional and therapeutic benefits, boosting growth, feed efficiency, and overall animal wellness. These additives can include antibiotics, antiparasitic agents, vitamins, or minerals, aimed at maintaining animal health, preventing infections, and enhancing productivity, thereby promoting effective livestock management and sustainable farming practices.
According to estimates from the European Food Safety Authority (EFSA), 320,000 food-borne and zoonotic diseases are reported annually in EU nations. This will affect the growth of the Medicated Feed Additives market revenue positively.
Driver
Growing concern for animal health and welfare
Heightened awareness around livestock health and ethical treatment is fueling demand for medicated feed additives. These additives play a vital role in preventing disease outbreaks, improving immunity, and enhancing overall animal productivity. With increasing scrutiny from consumers and regulators, producers are prioritizing welfare-friendly solutions that reduce reliance on antibiotics. Medicated additives offer targeted therapeutic benefits while supporting sustainable farming practices. The push for higher-quality meat and dairy products is also encouraging adoption across commercial farms. As welfare standards tighten globally, these additives are becoming essential tools for responsible animal husbandry.
Supply chain disruptions and price volatility
The medicated feed additives faces challenges from unstable supply chains and fluctuating raw material costs. Disruptions in sourcing active ingredients, vitamins, and minerals can delay production and strain inventory levels. Price swings in pharmaceutical compounds and feed-grade chemicals impact profitability and procurement planning. These uncertainties are particularly problematic for smaller manufacturers with limited buffer capacity. Regulatory delays and import restrictions further complicate logistics, especially in emerging markets. Overall, supply chain fragility and cost unpredictability remain key barriers to consistent market growth.
Rise of precision animal nutrition
The shift toward precision livestock nutrition is unlocking new growth avenues for medicated feed additives. Farmers and integrators are increasingly adopting data-driven approaches to optimize feed formulations based on species, age, and health status. This trend supports the use of targeted additives that deliver therapeutic benefits without overuse. Innovations in feed technology and diagnostics are enabling more accurate dosing and better health outcomes. As sustainability and efficiency become central to animal production, precision nutrition is gaining traction across poultry, swine, and ruminant sectors. Medicated additives are well-positioned to benefit from this evolution in feed strategy.
Competition from substitutes
The market is under pressure from alternative health solutions such as probiotics, phytogenics, and organic feed supplements. These substitutes are gaining popularity due to rising consumer demand for antibiotic-free and natural livestock products. Regulatory shifts favoring non-medicated interventions are also influencing purchasing decisions. In some cases, producers are switching to holistic health management strategies that reduce reliance on synthetic additives. The growing appeal of clean-label animal products poses a direct challenge to traditional medicated feed solutions. As a result, competition from substitutes is reshaping the market landscape and forcing innovation.
Covid-19 Impact
The pandemic initially disrupted the medicated feed additives market through supply chain breakdowns and reduced farm-level activity. Lockdowns affected feed production, veterinary services, and distribution networks, leading to temporary slowdowns. However, demand from essential sectors like poultry and dairy helped cushion the impact. The crisis underscored the importance of disease prevention and biosecurity, reinforcing the value of medicated additives. As operations resumed, producers prioritized resilient and health-focused feed strategies to mitigate future risks.
The antibiotics segment is expected to be the largest during the forecast period
The antibiotics segment is expected to account for the largest market share during the forecast period, propelled by the need to boost animal health, growth rates, and feed conversion efficiency. Innovations like controlled-release and microencapsulation technologies are enhancing delivery precision and drug stability. There's growing momentum around precision feeding and probiotic integration to curb antibiotic dependence. Regulatory shifts especially in Europe and Asia are catalyzing reformulations and sustainable alternatives, as manufacturers adapt to stricter veterinary compliance and evolving standards in livestock management.
The feed manufacturers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the feed manufacturers segment is predicted to witness the highest growth rate, driven by focusing on livestock health, performance, and regulatory alignment. Breakthroughs in nano-formulations and precision delivery systems are boosting additive efficiency and minimizing resource loss. A notable shift toward phytogenic ingredients and enzyme-based solutions is replacing traditional antibiotics. Recent developments include collaborative R&D initiatives, adoption of digital tracking tools, and reformulation efforts tailored to meet tightening regulations especially across Europe and Asia-Pacific driving innovation and compliance in feed production strategies.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising animal protein consumption, intensified livestock operations, and heightened awareness of disease prevention. Innovations in nano-delivery and precision dosing technologies are improving additive performance. There's a clear trend toward natural, enzyme-based solutions replacing conventional antibiotics. Major players like Cargill and Zoetis are ramping up R&D, while stricter regulations in India and China are prompting reformulations and the adoption of digital traceability systems to ensure compliance and optimize feed outcomes.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fueled by increasing consumer demand for antibiotic-free meat, tighter FDA oversight, and rising attention to animal health. Advances in immune-supporting and gut-targeted technologies are improving additive effectiveness. The market is shifting toward natural and organic feed options, reflecting sustainability-driven preferences. Leading companies like Zoetis and ADM are expanding research efforts, while digital traceability platforms are gaining traction to support regulatory compliance and enhance transparency across the feed supply chain.
Key players in the market
Some of the key players profiled in the Medicated Feed Additives Market include Phibro Animal Health Corporation, Novus International, Zoetis Inc., De Heus Animal Nutrition, Elanco Animal Health, Land O'Lakes Inc., Cargill Incorporated, Nutreco N.V., Archer Daniels Midland Company (ADM), BASF SE, Alltech Inc., CHS Inc., Kemin Industries, Evonik Industries AG, and Adisseo.
In June 2025, Zoetis Inc. has launched AI Masses, the newest addition to the Vetscan Imagyst(R) analyzer. AI Masses detects potentially neoplastic cells with accuracy1,2, supporting veterinary professionals to make informed decisions - streamlining diagnoses and clinic workflows. The newest indication enhances Zoetis' digital cytology offering by enabling fast, accurate1,2 AI analysis of lymph node and skin/subcutaneous masses, delivering results in minutes.
In June 2025, De Heus Animal Nutrition announces the acquisition of Voeders Huys, a well-established Belgian feed producer with production sites in Bruges (Belgium) and Northern France. This strategic move strengthens De Heus' position in Western Europe, a key region where the company has already experienced significant commercial growth and will now also produce locally.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.